Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity

Frontiers in Medicine

Nikita K. N. Jorritsma¹  Marianne Boes¹  Judith S. Spanjaard¹  Stefan Nierkens¹  Roy Spijkerman²  Leo Koenderman²  Suzanne H. Bongers³  Arnold C. Koekman⁴  Cor W. Seinen⁴  Steven de Maat⁴  Coen Maas⁴  Erhard van der Vries⁴  Silvie A. E. Sebastian⁴  Arjan D. Barendrecht⁴  Sandra Verhoef⁴  Chantal C. Clark⁴  Simone Smits⁴  Bernard N. Jukema⁴  Annet C. W. van Wesel⁴  Naomi M. J. Parr⁴  Karin A. H. Kaasjager⁵  Harriet M. R. van Goor⁵ 

[1] Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Department of Trauma Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Department of Central Diagnostic Laboratory Research, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;Department of Internal Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;

关键词: COVID-19;    platelets;    SARS-CoV-2;    thrombosis;    thrombotic event;    pulmonary thrombosis;    thromboinflammation;   

DOI  :  10.3389/fmed.2021.650129

来源: Frontiers

【 授权许可】

CC BY